Yesterday I opened founding copies of the Remission Series. Today I want to show you why it's built the way it is — because in this market, the burden of proof is on me.
Search “reverse type 2 diabetes” and you'll find people promising it in 17 days, usually right before selling you a supplement. Here's what the research actually shows: in the best remission trial we have (DiRECT, a UK study), about one-third of carefully selected people — mostly recently diagnosed — reached remission at two years, and roughly half of those saw it slip away by year five. Remission is real. It is documented. And it is not guaranteed — for some people, it was never biologically on the table.
I could hide that. It would sell more books. Instead it's in the introduction of Book 1, because you can't make good decisions with numbers someone massaged.
What that honesty buys you in practice:
Every claim is referenced. Studies are named, not gestured at. You can check anything — and I'd rather you did.
Medication safety comes first. Book 2's program opens with what to discuss with your doctor before changing anything — especially if you take insulin or a sulfonylurea. These guides work with your care, never around it.
There is no upsell machine. Three books and a bundle. No $497 masterclass behind them, no supplement subscription, no coaching funnel. What you buy is what exists.
Two dates worth knowing: the free printable Tracker Pack goes to anyone who buys before midnight Eastern tomorrow, Wednesday, July 15 — and the $87 founding price runs until Tuesday, July 21, when the bundle moves to $97 for good.
And as I said yesterday: if the free emails are doing the job for you, skip this with a clear conscience. Nothing changes.
— Alistair
PureNovus
Educational, not medical advice.